Ohya, S., M. Matsui, and J. Kajikuri. “Ca 2+ -Activated K + Channel K Ca 3.1 As a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease”. Journal of Gastrointestinal and Liver Diseases, vol. 29, no. 4, Dec. 2020, pp. 487-9, doi:10.15403/jgld-3234.